Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

BACKGROUND: Thiazolidinediones (TZDs), rosiglitazone (RGZ) and pioglitazone (PGZ) are widely used as hypoglycemic drugs in patients with type 2 diabetes mellitus. The aim of our study was to investigate the profile of adverse drug reactions (ADRs) related to TZDs and to investigate potential risk fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Berthet, Stephanie, Olivier, Pascale, Montastruc, Jean-Louis, Lapeyre-Mestre, Maryse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119167/
https://www.ncbi.nlm.nih.gov/pubmed/21609444
http://dx.doi.org/10.1186/1472-6904-11-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119167/
https://www.ncbi.nlm.nih.gov/pubmed/21609444
http://dx.doi.org/10.1186/1472-6904-11-5

Ejemplares similares